An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis
International Journal of Experimental Pathology · 2013-04 · 94 (2) · 93-103
DOI: 10.1111/iep.12008 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Experimental Pathology, online erschienen am 11.01.2013. Verfasst von Masahiko Matsumoto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fuji-Gotemba Research Laboratories, Chugai Research Institute for Medical Science Inc, Gotemba, Shizuoka, Japan. Hauptthemen laut MEDLINE: Disease Models, Animal, Mice, Inbred C57BL. Die Arbeit wurde bisher 520-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Non‐alcoholic steatohepatitis ( NASH ) is a progressive fibrotic disease, the pathogenesis of which has not been fully elucidated. One of the most common models used in NASH research is a nutritional model where NASH is induced by feeding a diet deficient in both methionine and choline. However, the dietary methionine‐/choline‐deficient model in mice can cause severe weight loss and liver atrophy, which are not characteristics of NASH seen in human patients. Exclusive, long‐term feeding with a high‐fat diet ( HFD ) produced fatty liver and obesity in mice, but the HFD for several months did not affect fibrosis. We aimed to establish a mouse model of NASH with fibrosis by optimizing the methionine content in the HFD . Male mice were fed a choline‐deficient, L ‐amino acid‐defined, high‐fat diet ( CDAHFD ) consisting of 60 kcal% fat and 0.1% methionine by weight. After 1–14 weeks of being fed CDAHFD , the mice were killed. C 57 BL /6 J mice maintained or gained weight when fed CDAHFD , while A/J mice showed a steady decline in body weight (of up to 20% of initial weight). In both strains of mice, plasma levels of alanine aminotransferase increased from week 1, when hepatic steatosis was also observed. By week 6, C 57 BL /6 J mice had developed enlarged fatty liver with fibrosis as assessed by M asson's trichrome staining and by hydroxyproline assay. Therefore, this improved CDAHFD model may be a mouse model of rapidly progressive liver fibrosis and be potentially useful for better understanding human NASH disease and in the development of efficient therapies for this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fuji-Gotemba Research Laboratories, Chugai Research Institute for Medical Science Inc, Gotemba, Shizuoka, Japan.
Zitieren
APA
Matsumoto, M., Hada, N., Sakamaki, Y., Uno, A., Shiga, T., Tanaka, C., Ito, T., Katsume, A., & Sudoh, M. (2013). An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis. International Journal of Experimental Pathology, 94(2), 93-103. https://doi.org/10.1111/iep.12008
Vancouver
Matsumoto M, Hada N, Sakamaki Y, Uno A, Shiga T, Tanaka C, et al. An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis. International Journal of Experimental Pathology. 2013;94(2):93-103. doi:10.1111/iep.12008
BibTeX
@article{Matsumoto2013,
author = {Matsumoto, Masahiko and Hada, Natsuko and Sakamaki, Yoshiyuki and Uno, Akiko and Shiga, Toshihiko and Tanaka, Chiaki and Ito, Tsuneo and Katsume, Asao and Sudoh, Masayuki},
title = {An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis},
journal = {International Journal of Experimental Pathology},
year = {2013},
volume = {94},
number = {2},
pages = {93--103},
doi = {10.1111/iep.12008}
}
EUVIMED